Global Animal Therapeutics and Diagnostics Market

Animal Therapeutics and Diagnostics Comprehensive Study by Type (Animal Diagnostics Products (Instruments, Consumables), Animal Therapeutics Products (Anti-Parasitic Drugs and Antibiotics, Anti-Inflammatory Drugs, Anesthetics, Other Drugs)), Application (Companion Animals (Dogs, Cats), Other Companion Animals (Cattle, Pigs, Poultry, Sheep)), End User (Veterinary Hospitals, Research Organizations) Players and Region - Global Market Outlook to 2028

Animal Therapeutics and Diagnostics Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Animal Therapeutics and Diagnostics Market Scope?
The animal therapeutics and diagnostics market is expected to rise in the forecasted period due to the growing demand for rapid tests and portable instruments for point-of-care services. The growth in this market is driven by the increasing companion animal population and an increasing number of veterinary practitioners in developed economies. Nowadays there has been significant innovation in the range of treatments available for the treatment of animals. Furthermore, rising government initiatives for the promotion of pet health will escalate industry growth in the upcoming year.

Influencing Trend:
Technological Advancement in Diagnostic Instruments and Surging Research and Development on Therapeutic Drugs and Diagnostic Instruments

Market Growth Drivers:
Increasing Demand for Animal-derived Food Products such as Meat, Rising Focus towards Animal Well-being and Increasing Government Initiatives for Promotion of Pet Health

Challenges:
Stringent Government Medical and Surgical Devices Regulations

Restraints:
Lack of Awareness Regarding Animal Healthcare and High Cost of Therapy and Diagnosis

Opportunities:
Increasing Veterinary Practitioners in Developed Regions, Surging Expenditure on Animal Health and Pet Insurance and Increase in Investments by Large Scale Pharmaceutical Companies in Animal Health Care Companies

The Animal Therapeutics and Diagnostics market study is being classified by Type (Animal Diagnostics Products (Instruments, Consumables) and Animal Therapeutics Products (Anti-Parasitic Drugs and Antibiotics, Anti-Inflammatory Drugs, Anesthetics, Other Drugs)), by Application and major geographies with country level break-up.

The market is moderately fragmented owing to the presence of several key players within the industry. Some of the leading players are adopting some organic and inorganic strategies such as a merger, acquisition, product launches, and expansion among others in order to gain leading share within the market. Moreover, some of the prominent vendors are focusing on technological advancements in order to cater to safety features as per the market necessities. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Animal Therapeutics and Diagnostics market throughout the predicted period.

Bayer HealthCare (Germany), Pfizer (United States), Eli Lilly (United States), Boehringer Ingelheim (Germany), Merck (United States), Zoetis (United States), Ceva (United States), Sanofi S.A. (France) and Nutreco N.V. (Netherlands) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Virbac (France) and IDEXX Laboratories Inc (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Animal Therapeutics and Diagnostics market by Type, Application and Region.

On the basis of geography, the market of Animal Therapeutics and Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In July 2018, Zoetis Inc. announced the completion of the acquisition of Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services.
In Aug 2019, Elanco Animal Health Incorporated has announced the acquisition of Montreal-based Prevtec Microbia Inc. (Prevtec), a biotechnology startup specializing in the development of vaccines that help prevent bacterial diseases in food animals.
“According to Food, Drug, and Cosmetic Act (FDA), it recommends that manufacturers and distributors of veterinary medical devices request a review of their product labeling and promotional literature to ensure compliance with the act. This recommendation also applies to devices marketed in another country or imported into the US.”

Key Target Audience
New Entrants/Investors, Healthcare Industry Associations, Venture Capitalists and Private Equity Firms, Animal Therapeutics and Diagnostics Provider, End-Use Industries, Analysts and Strategic Business Planners and Others

Animal Therapeutics and Diagnostics Market Study: Important Years
AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Animal Therapeutics and Diagnostics Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Animal Therapeutics and Diagnostics industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Animal Diagnostics Products (Instruments, Consumables)
  • Animal Therapeutics Products (Anti-Parasitic Drugs and Antibiotics, Anti-Inflammatory Drugs, Anesthetics, Other Drugs)
By Application
  • Companion Animals (Dogs, Cats)
  • Other Companion Animals (Cattle, Pigs, Poultry, Sheep)
By End User
  • Veterinary Hospitals
  • Research Organizations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Animal-derived Food Products such as Meat
      • 3.2.2. Rising Focus towards Animal Well-being
      • 3.2.3. Increasing Government Initiatives for Promotion of Pet Health
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Medical and Surgical Devices Regulations
    • 3.4. Market Trends
      • 3.4.1. Technological Advancement in Diagnostic Instruments
      • 3.4.2. Surging Research and Development on Therapeutic Drugs and Diagnostic Instruments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Therapeutics and Diagnostics, by Type, Application, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Animal Therapeutics and Diagnostics (Value)
      • 5.2.1. Global Animal Therapeutics and Diagnostics by: Type (Value)
        • 5.2.1.1. Animal Diagnostics Products (Instruments, Consumables)
        • 5.2.1.2. Animal Therapeutics Products (Anti-Parasitic Drugs and Antibiotics, Anti-Inflammatory Drugs, Anesthetics, Other Drugs)
      • 5.2.2. Global Animal Therapeutics and Diagnostics by: Application (Value)
        • 5.2.2.1. Companion Animals (Dogs, Cats)
        • 5.2.2.2. Other Companion Animals (Cattle, Pigs, Poultry, Sheep)
      • 5.2.3. Global Animal Therapeutics and Diagnostics by: End User (Value)
        • 5.2.3.1. Veterinary Hospitals
        • 5.2.3.2. Research Organizations
      • 5.2.4. Global Animal Therapeutics and Diagnostics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Animal Therapeutics and Diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer HealthCare (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Eli Lilly (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boehringer Ingelheim (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Zoetis (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ceva (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sanofi S.A. (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nutreco N.V. (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Animal Therapeutics and Diagnostics Sale, by Type, Application, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Animal Therapeutics and Diagnostics (Value)
      • 7.2.1. Global Animal Therapeutics and Diagnostics by: Type (Value)
        • 7.2.1.1. Animal Diagnostics Products (Instruments, Consumables)
        • 7.2.1.2. Animal Therapeutics Products (Anti-Parasitic Drugs and Antibiotics, Anti-Inflammatory Drugs, Anesthetics, Other Drugs)
      • 7.2.2. Global Animal Therapeutics and Diagnostics by: Application (Value)
        • 7.2.2.1. Companion Animals (Dogs, Cats)
        • 7.2.2.2. Other Companion Animals (Cattle, Pigs, Poultry, Sheep)
      • 7.2.3. Global Animal Therapeutics and Diagnostics by: End User (Value)
        • 7.2.3.1. Veterinary Hospitals
        • 7.2.3.2. Research Organizations
      • 7.2.4. Global Animal Therapeutics and Diagnostics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Therapeutics and Diagnostics: by Type(USD Million)
  • Table 2. Animal Therapeutics and Diagnostics Animal Diagnostics Products (Instruments, Consumables) , by Region USD Million (2017-2022)
  • Table 3. Animal Therapeutics and Diagnostics Animal Therapeutics Products (Anti-Parasitic Drugs and Antibiotics, Anti-Inflammatory Drugs, Anesthetics, Other Drugs) , by Region USD Million (2017-2022)
  • Table 4. Animal Therapeutics and Diagnostics: by Application(USD Million)
  • Table 5. Animal Therapeutics and Diagnostics Companion Animals (Dogs, Cats) , by Region USD Million (2017-2022)
  • Table 6. Animal Therapeutics and Diagnostics Other Companion Animals (Cattle, Pigs, Poultry, Sheep) , by Region USD Million (2017-2022)
  • Table 7. Animal Therapeutics and Diagnostics: by End User(USD Million)
  • Table 8. Animal Therapeutics and Diagnostics Veterinary Hospitals , by Region USD Million (2017-2022)
  • Table 9. Animal Therapeutics and Diagnostics Research Organizations , by Region USD Million (2017-2022)
  • Table 10. South America Animal Therapeutics and Diagnostics, by Country USD Million (2017-2022)
  • Table 11. South America Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 12. South America Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 13. South America Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 14. Brazil Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 15. Brazil Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 16. Brazil Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 17. Argentina Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 18. Argentina Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 19. Argentina Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 20. Rest of South America Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 21. Rest of South America Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 22. Rest of South America Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 23. Asia Pacific Animal Therapeutics and Diagnostics, by Country USD Million (2017-2022)
  • Table 24. Asia Pacific Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 25. Asia Pacific Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 26. Asia Pacific Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 27. China Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 28. China Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 29. China Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 30. Japan Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 31. Japan Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 32. Japan Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 33. India Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 34. India Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 35. India Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 36. South Korea Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 37. South Korea Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 38. South Korea Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 39. Taiwan Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 40. Taiwan Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 41. Taiwan Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 42. Australia Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 43. Australia Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 44. Australia Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 45. Rest of Asia-Pacific Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 46. Rest of Asia-Pacific Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 47. Rest of Asia-Pacific Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 48. Europe Animal Therapeutics and Diagnostics, by Country USD Million (2017-2022)
  • Table 49. Europe Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 50. Europe Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 51. Europe Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 52. Germany Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 53. Germany Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 54. Germany Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 55. France Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 56. France Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 57. France Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 58. Italy Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 59. Italy Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 60. Italy Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 61. United Kingdom Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 62. United Kingdom Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 63. United Kingdom Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 64. Netherlands Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 65. Netherlands Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 66. Netherlands Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 67. Rest of Europe Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 68. Rest of Europe Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 69. Rest of Europe Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 70. MEA Animal Therapeutics and Diagnostics, by Country USD Million (2017-2022)
  • Table 71. MEA Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 72. MEA Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 73. MEA Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 74. Middle East Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 75. Middle East Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 76. Middle East Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 77. Africa Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 78. Africa Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 79. Africa Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 80. North America Animal Therapeutics and Diagnostics, by Country USD Million (2017-2022)
  • Table 81. North America Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 82. North America Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 83. North America Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 84. United States Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 85. United States Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 86. United States Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 87. Canada Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 88. Canada Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 89. Canada Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 90. Mexico Animal Therapeutics and Diagnostics, by Type USD Million (2017-2022)
  • Table 91. Mexico Animal Therapeutics and Diagnostics, by Application USD Million (2017-2022)
  • Table 92. Mexico Animal Therapeutics and Diagnostics, by End User USD Million (2017-2022)
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Animal Therapeutics and Diagnostics: by Type(USD Million)
  • Table 103. Animal Therapeutics and Diagnostics Animal Diagnostics Products (Instruments, Consumables) , by Region USD Million (2023-2028)
  • Table 104. Animal Therapeutics and Diagnostics Animal Therapeutics Products (Anti-Parasitic Drugs and Antibiotics, Anti-Inflammatory Drugs, Anesthetics, Other Drugs) , by Region USD Million (2023-2028)
  • Table 105. Animal Therapeutics and Diagnostics: by Application(USD Million)
  • Table 106. Animal Therapeutics and Diagnostics Companion Animals (Dogs, Cats) , by Region USD Million (2023-2028)
  • Table 107. Animal Therapeutics and Diagnostics Other Companion Animals (Cattle, Pigs, Poultry, Sheep) , by Region USD Million (2023-2028)
  • Table 108. Animal Therapeutics and Diagnostics: by End User(USD Million)
  • Table 109. Animal Therapeutics and Diagnostics Veterinary Hospitals , by Region USD Million (2023-2028)
  • Table 110. Animal Therapeutics and Diagnostics Research Organizations , by Region USD Million (2023-2028)
  • Table 111. South America Animal Therapeutics and Diagnostics, by Country USD Million (2023-2028)
  • Table 112. South America Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 113. South America Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 114. South America Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 115. Brazil Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 116. Brazil Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 117. Brazil Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 118. Argentina Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 119. Argentina Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 120. Argentina Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 121. Rest of South America Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 122. Rest of South America Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 123. Rest of South America Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 124. Asia Pacific Animal Therapeutics and Diagnostics, by Country USD Million (2023-2028)
  • Table 125. Asia Pacific Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 126. Asia Pacific Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 127. Asia Pacific Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 128. China Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 129. China Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 130. China Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 131. Japan Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 132. Japan Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 133. Japan Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 134. India Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 135. India Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 136. India Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 137. South Korea Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 138. South Korea Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 139. South Korea Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 140. Taiwan Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 141. Taiwan Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 142. Taiwan Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 143. Australia Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 144. Australia Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 145. Australia Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 146. Rest of Asia-Pacific Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 147. Rest of Asia-Pacific Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 148. Rest of Asia-Pacific Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 149. Europe Animal Therapeutics and Diagnostics, by Country USD Million (2023-2028)
  • Table 150. Europe Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 151. Europe Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 152. Europe Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 153. Germany Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 154. Germany Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 155. Germany Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 156. France Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 157. France Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 158. France Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 159. Italy Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 160. Italy Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 161. Italy Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 162. United Kingdom Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 163. United Kingdom Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 164. United Kingdom Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 165. Netherlands Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 166. Netherlands Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 167. Netherlands Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 168. Rest of Europe Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 169. Rest of Europe Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 170. Rest of Europe Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 171. MEA Animal Therapeutics and Diagnostics, by Country USD Million (2023-2028)
  • Table 172. MEA Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 173. MEA Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 174. MEA Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 175. Middle East Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 176. Middle East Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 177. Middle East Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 178. Africa Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 179. Africa Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 180. Africa Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 181. North America Animal Therapeutics and Diagnostics, by Country USD Million (2023-2028)
  • Table 182. North America Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 183. North America Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 184. North America Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 185. United States Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 186. United States Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 187. United States Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 188. Canada Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 189. Canada Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 190. Canada Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 191. Mexico Animal Therapeutics and Diagnostics, by Type USD Million (2023-2028)
  • Table 192. Mexico Animal Therapeutics and Diagnostics, by Application USD Million (2023-2028)
  • Table 193. Mexico Animal Therapeutics and Diagnostics, by End User USD Million (2023-2028)
  • Table 194. Research Programs/Design for This Report
  • Table 195. Key Data Information from Secondary Sources
  • Table 196. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Therapeutics and Diagnostics: by Type USD Million (2017-2022)
  • Figure 5. Global Animal Therapeutics and Diagnostics: by Application USD Million (2017-2022)
  • Figure 6. Global Animal Therapeutics and Diagnostics: by End User USD Million (2017-2022)
  • Figure 7. South America Animal Therapeutics and Diagnostics Share (%), by Country
  • Figure 8. Asia Pacific Animal Therapeutics and Diagnostics Share (%), by Country
  • Figure 9. Europe Animal Therapeutics and Diagnostics Share (%), by Country
  • Figure 10. MEA Animal Therapeutics and Diagnostics Share (%), by Country
  • Figure 11. North America Animal Therapeutics and Diagnostics Share (%), by Country
  • Figure 12. Global Animal Therapeutics and Diagnostics share by Players 2022 (%)
  • Figure 13. Global Animal Therapeutics and Diagnostics share by Players (Top 3) 2022(%)
  • Figure 14. Global Animal Therapeutics and Diagnostics share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Bayer HealthCare (Germany) Revenue, Net Income and Gross profit
  • Figure 17. Bayer HealthCare (Germany) Revenue: by Geography 2022
  • Figure 18. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 19. Pfizer (United States) Revenue: by Geography 2022
  • Figure 20. Eli Lilly (United States) Revenue, Net Income and Gross profit
  • Figure 21. Eli Lilly (United States) Revenue: by Geography 2022
  • Figure 22. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Boehringer Ingelheim (Germany) Revenue: by Geography 2022
  • Figure 24. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 25. Merck (United States) Revenue: by Geography 2022
  • Figure 26. Zoetis (United States) Revenue, Net Income and Gross profit
  • Figure 27. Zoetis (United States) Revenue: by Geography 2022
  • Figure 28. Ceva (United States) Revenue, Net Income and Gross profit
  • Figure 29. Ceva (United States) Revenue: by Geography 2022
  • Figure 30. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 31. Sanofi S.A. (France) Revenue: by Geography 2022
  • Figure 32. Nutreco N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 33. Nutreco N.V. (Netherlands) Revenue: by Geography 2022
  • Figure 34. Global Animal Therapeutics and Diagnostics: by Type USD Million (2023-2028)
  • Figure 35. Global Animal Therapeutics and Diagnostics: by Application USD Million (2023-2028)
  • Figure 36. Global Animal Therapeutics and Diagnostics: by End User USD Million (2023-2028)
  • Figure 37. South America Animal Therapeutics and Diagnostics Share (%), by Country
  • Figure 38. Asia Pacific Animal Therapeutics and Diagnostics Share (%), by Country
  • Figure 39. Europe Animal Therapeutics and Diagnostics Share (%), by Country
  • Figure 40. MEA Animal Therapeutics and Diagnostics Share (%), by Country
  • Figure 41. North America Animal Therapeutics and Diagnostics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bayer HealthCare (Germany)
  • Pfizer (United States)
  • Eli Lilly (United States)
  • Boehringer Ingelheim (Germany)
  • Merck (United States)
  • Zoetis (United States)
  • Ceva (United States)
  • Sanofi S.A. (France)
  • Nutreco N.V. (Netherlands)
Additional players considered in the study are as follows:
Virbac (France) , IDEXX Laboratories Inc (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 213 Pages 71 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Animal Therapeutics and Diagnostics Market Quantitative research analysis
Global Animal Therapeutics and Diagnostics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Animal Therapeutics and Diagnostics market are Bayer HealthCare (Germany), Pfizer (United States), Eli Lilly (United States), Boehringer Ingelheim (Germany), Merck (United States), Zoetis (United States), Ceva (United States), Sanofi S.A. (France) and Nutreco N.V. (Netherlands).
In this highly competitive & fast evolving Animal Therapeutics and Diagnostics industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Companion Animals (Dogs, Cats) and Other Companion Animals (Cattle, Pigs, Poultry, Sheep) are the potential customers of Animal Therapeutics and Diagnostics industry.

Know More About Global Animal Therapeutics and Diagnostics Market Report?

Have a Query? Click Here

Other Related Reports

Irritable Bowel Syndrome Treatment Comprehensive Study by Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Ramosetron Hydrochloride, Others), Distribution Channel (Hospital Pharmacies, Online...
$ 3450
Cancer Test Comprehensive Study by Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), Application (Bladder Cancer Test, Breast Cancer Test, Cervical Cancer Test, Colorectal (Colon) Cancer Te...
$ 3650
Dermatological Therapeutics Comprehensive Study by Type (Anti-infectives , Corticosteroids, Anti Psoriasis, Anti-acne , Others), Application (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopec...
$ 3750
Thyroid Cancer Treatment Comprehensive Study by Type (Surgery, Iodine Therapy, External Radiotherapy, Thyroxin Treatment, Chemotherapy, Drugs), Application (Hospitals, Oncology centers, Hospital Phar...
$ 3650
Urinary Tract Cancer Comprehensive Study by Type (Urothelial Carcinoma, Squamous Cell Carcinoma, Adenocarcinoma, Others), Diagnosis Technique (Cytoscopy, Urine Analyses, Biopsy, Imaging Test (Compute...
$ 3750
Mesenchymal Stem Cells Comprehensive Study by Type (MSC-BM, MSC-UC, MSC-AT, Others), Application (Cell Differentiation and Gene Regulation, Gene Therapy and Transplantation, Cell-based Screening Assa...
$ 3500